A comparison of the proportions of CD3+, CD4+, CD8+, and CD4+Treg+ cells in PBMC, TDLN, and tumor revealed that TDLN was skewed toward either PBMC or the tumor, depending on which subset one looks at. This evidence concerns the gene CD4 and neoplasm.